Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients
AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients
AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients
Submitted by
admin
on October 30, 2015 - 11:17am
Source:
Fierce Biotech
News Tags:
AstraZeneca
olaparib
Lynparza
prostate cancer
ovarian cancer
Headline:
AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients
Do Not Allow Advertisers to Use My Personal information
